These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4843878)

  • 1. Control of tumor growth in mice by thoracic duct drainage: relationship to blocking factor in lymph.
    Noonan FP; Gardner MA; Clunie GJ; Isbister WH; Halliday WJ
    Int J Cancer; 1974 May; 13(5):640-9. PubMed ID: 4843878
    [No Abstract]   [Full Text] [Related]  

  • 2. Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanoma.
    Isbister WH; Noonan FP; Halliday WJ; Clunie GJ
    Cancer; 1975 May; 35(5):1465-71. PubMed ID: 1122496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the rat immune response to plasmacytoma 5563 in C3H mice.
    Fakhri O; Hobbs JR
    Br J Cancer; 1970 Dec; 24(4):853-60. PubMed ID: 5503607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Manipulation of blocking factor and its effect on tumour growth in mice.
    Clunie CJ; Noonan FP; Gardner MA; Halliday WJ; Isbister WH; Burnett W
    Br J Surg; 1974 Apr; 61(4):322. PubMed ID: 4832651
    [No Abstract]   [Full Text] [Related]  

  • 7. Some properties of adenovirus 12-induced transplantation antigen, as measured by the macrophage migration inhibition test.
    Potter CW; Rees RC
    Eur J Cancer (1965); 1975 May; 11(5):335-41. PubMed ID: 239847
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of mixed lymphocyte reaction by thoracic duct lymph: removal of inhibitory effect by thoracic duct drainage in lung cancer.
    Han T; Takita H
    J Surg Oncol; 1976; 8(3):237-43. PubMed ID: 132573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
    Schlott B; Gryschek G; Albrecht S; Pasternak G
    Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum factors that inhibit in vitro immunological reactions in malignant tumor development in experimental animals].
    Lomakin MS; Larin AS; Mamaeva TN; Levitina VL
    Vopr Onkol; 1977; 23(10):76-82. PubMed ID: 202095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen--antibody complexes as blocking factors on the T lymphocyte surface.
    Gorczynski R; Kontiainen S; Mitchison NA; Tigelaar RE
    Soc Gen Physiol Ser; 1974; 29():143-54. PubMed ID: 4139762
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. 3. Demonstration of this antigen on the lymphoreticular system of adult mice.
    Rejthar A; Wotke J
    Folia Biol (Praha); 1974; 20(4):244-51. PubMed ID: 4472054
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors interfering with immunological rejection of tumours.
    Baldwin RW; Robins RA
    Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
    Churchill WH; Zbar B; Belli JA; David JR
    J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chronic thoracic duct drainage on cell antigenicity.
    Mandel MA
    J Surg Oncol; 1974; 6(6):501-9. PubMed ID: 4453129
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of experimental tumors.
    Alexander P
    Proc R Soc Med; 1971 Oct; 64(10):1042-3. PubMed ID: 5169325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.